CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for IXICO plc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

IXICO plc
4th Floor, Griffin Court
15 Long Lane
Phone: +44 2037637499p:+44 2037637499 London, EC1A 9PN  United Kingdom Ticker: IXIIXI
Business Summary
IXICO plc is a United Kingdom-based company that provides specialist data analytics services to the global biopharmaceutical industry. The services include the collection, analysis, management, and reporting on data generated in the course of a clinical study. The outputs from the data analysis are used to enhance patient selection, monitor drug safety, and assess clinical efficacy of the drug under development. It offers a range of services, such as drug development analytics, imaging operations, post-marketing, and post-marketing. It offers end to end services, including trial design and consultation, project management, imaging site set-up and management, data management, reading and analysis, and regulatory pathway. It offers a range of clinical trial imaging analysis tools, including radiological reads, structural and advanced magnetic resonance imaging (MRI). Its specialist data analytics services identify and measure biomarkers from brain scans and wearable biosensors.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/20239/30/2023YesYes---

Industries
SIC Code Description
6719 Offices of holding companies, not elsewhere classified
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Chairman of the Board Mark R.Warne 47 1/25/2024 9/16/2016
Chief Executive Officer, Executive Director GiulioCerroni 61 2/6/2017 2/6/2017
Chief Financial Officer, Executive Director, Company Secretary Grant R.Nash 46 5/31/2019 4/29/2019
Non-Executive Director Katherine J.Rogers 57 1/21/2022 1/21/2022
Non-Executive Independent Director DiptiAmin 59 10/5/2023 10/5/2023

Business Names
Business Name
A1W23U
IXI
IXICO PLC
8 additional Business Names available in full report.

General Information
Number of Employees: 89 (As of 9/30/2023)
Outstanding Shares: 48,351,373 (As of 9/30/2023)
Shareholders: 2,529
Stock Exchange: LON
Fax Number: +44 2072092473


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 19, 2024